A Study of Niraparib in Patients With Relapsed Ovarian Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Ovarian Cancer
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04392102
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Rutie Yin West China Second University Hospital Principal Investigator: Xiaohua Wu Fudan University Principal Investigator: Hong Zheng Beijing Cancer Hospital Principal Investigator: Ge Lou Harbin Medical University Principal Investigator: Lingying Wu Cancer Institute and Hospital, Chinese Academy of Medical Sciences Principal Investigator: Hongmin Pan Sir Run Shaw Hospital, school of medicine, Zhejiang University Principal Investigator: Zhongqiu Lin Sun Yat-sen Memorial Hospital,Sun Yat-sen University
Get Well Soon